Tarbox Family Office’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8
Closed -$1K 1116
2021
Q3
$1K Buy
8
+7
+700% +$815 ﹤0.01% 1018
2021
Q2
$0 Hold
1
﹤0.01% 1148
2021
Q1
$0 Hold
1
﹤0.01% 1148
2020
Q4
$0 Hold
1
﹤0.01% 1139
2020
Q3
$0 Buy
+1
New +$111 ﹤0.01% 1149

Other funds holding AZN

Tarbox Family Office's AZN Position: Q4 2021 in Review

Tarbox Family Office sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 8 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in AZN in Q3 2020 and held it in 5 quarters. The position peaked at $1K in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

  • Tarbox Family Office reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 8 AstraZeneca shares in Q4 2021, an estimated $1K.
  • Tarbox Family Office first reported a position in AstraZeneca in Q3 2020 and held it in 5 quarters.
  • Tarbox Family Office's AstraZeneca position peaked at $1K in Q3 2021.
  • 949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.